Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns

Applied Microbiology and Biotechnology

Volumn 96, Issue 6, 2012, Pages 1561-1576

  Aloisio, Irene ^a   Santini, Cecilia ^a   Biavati, Bruno ^a   Dinelli, Giovanni ^a   Cencič, Avrelija ^b   Chingwaru, Walter ^b   Mogna, Luca ^c   Di Gioia, Diana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c Probiotical SpA   (Italy)

Author keywords

Bifidobacterium; Enteric disorders; Newborns; Nontumorigenic cell lines; Probiotics

Indexed keywords

BIFIDOBACTERIUM; ENTERIC DISORDERS; NEWBORNS; NONTUMORIGENIC CELLS; PROBIOTICS;

CELL CULTURE; ENZYME ACTIVITY;

STRAIN;

AMOXICILLIN; AMPICILLIN; KANAMYCIN; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; STREPTOMYCIN; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOTECHNOLOGY; CHILD HEALTH; DIGESTIVE SYSTEM DISORDER; DISEASE TREATMENT; GROWTH; INHIBITION; NEONATE; PROBIOTICS;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CAMPYLOBACTER JEJUNI; CELL ADHESION; COLIC; COLIFORM BACTERIUM; CONTROLLED STUDY; CYTOTOXICITY; GASTROINTESTINAL TRACT; GENOTYPE; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFANT; INTESTINE EPITHELIUM CELL; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE;

BIFIDOBACTERIUM; COLIC; FECES; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; PROBIOTICS;

BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; LACTOBACILLUS;

EID: 84871059100     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4138-5     Document Type: Article

References (50)

1. Aires J, Doucet-Populaire F, Butel MJ (2007) Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans. Appl Environ Microbiol 73: 2751-2754
2. Ammor MS, Flórez AB, Van Hoek AHAM, De Los Reyes-Gavilán CG, Aarts HJM, Margolles A, Mayo B (2008) Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria. J Mol Microbiol Biotechnol 14: 6-15
3. Arboleya S, Ruas-Madiedo P, Margolles A, Solis G, Salminen S, De los Reyes-Gavilan CG, Gueimonde M (2011) Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk. Int J Food Microbiol 149: 28-36
4. Benzecri JP (1992) Correspondence analyses handbook. CRC Press, Boca Raton
5. Biavati B, Mattarelli P (2006) The Family Bifidobacteriaceae prokaryotes: a handbook on the biology of bacteria, 3rd ed, vol 3. Springer, New York, pp 322-382
6. Burrus V, Waldor MK (2003) Control of SXT integration and excision. J Bacteriol 185: 5045-5054
7. Cencic A, Langerholc T (2010) Functional cell models of the gut and their applications in food microbiology - a review. Int J Food Microbiol 141: S4-S14
8. D'Aimmo MR, Modesto M, Biavati B (2007) Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int J Food Microbiol 115: 35-42
9. EFSA (2005) Opinion of the scientific committee on a request from EFSA related to a generic approach to the safety assessment by EFSA of microorganisms used in food/feed and the production of food/feed additives. EFSA J 226: 1-12
10. EFSA (2008) Opinion of the Scientific Panel on Additives and Products or Substances used in Animal Feed on the updating of the criteria used in the assessment of bacteria for resistance to antibiotics of human or veterinary importance. EFSA Journal 223: 1-12
11. Guarner F (2006) Enteric flora in health and disease. Digestion 73: 5-12
12. Hammerman C, Bin-Nun A, Kaplan M (2006) Safety of probiotics: comparision of two popular strains. BMJ 333: 1006-1008
13. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R (2008) The effects of probiotics on feeling tolarance, bowel habitus and gastrointestinal motility in preterm newborns. J Pediatr 152: 801-806
14. Ivec M, Botic T, Koren S, Jakobsen M, Weingartl H, Cencic A (2007) Interaction of macrophages with probiotic bacteria lead to increase antiviral response against vesicular stomatitis virus. Antiviral Res 75: 266-274
15. Kiwaki M, Sato T (2009) Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int J Food Microbiol 134: 211-215
16. Lampkowska J, Feld L, Monaghan A, Toomey N, Schjørring S, Jacobsen B (2008) A standardized conjugation protocol to asses antibiotic resistance transfer between lactococcal species. Int J Food Microbiol 127: 172-175
17. Li Y, Shimizu T, Hosaka A, Kaneko N, Ohtsuka Y, Yamashiro Y (2004) Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 46: 509-515
18. Lin J (2004) Too much short chain fatty acids cause neonatal necrotizing enterocolitis. Med Hypotheses 62: 291-293
19. Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A (2010) Lactic acid bacteria efficiently protect human and animal epithelial and immune cells from enteric virus infection. Int J Food Microbiol 141: S91-S97
20. Masco L, Van Hoorde K, De Brandt E, Swings J, Huys G (2006) Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. J Antimicrob Chemother 58: 85-94
21. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65: 4506-4512
22. Matto J, Vanhoek A, Domig K, Saarela M, Florez A, Brockmann E (2007) Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method. Int Diary J 17: 1123-1131
23. Mohan R, Koebnick C, Schildt J, Schmidt S, Mueller M, Possner M (2006) Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebocontrolled, randomized study. J Clin Microbiol 44: 4025-4031
24. Nissen L, Chingwaru W, Sgorbati B, Biavati B, Cencic A (2009) Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. Int J Food Microbiol 135: 288-294
25. Ouoba L, Lei V, Jensen LB (2008) Resistance of potential probiotic lactic acid bacteria and bifidobacteria of African and European origin to antimicrobials: determination and transferability of the resistance genes to other bacteria. Int J Food Microbiol 121: 217-224
26. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5: 1556-1573
27. Park SY, Ji GE, Ko YT, Jung HK, Ustunol Z, Pestka JJ (1999) Potential of hydrogen peroxide, nitric oxide and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46: 231-241
28. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, Van Den Brandt PA (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118: 511-521
29. Pipenbaher N, Moeller PL, Dolinšek J, Jakobsen M, Weingartl H, Cencic A (2009) Nitric oxide (NO) production in mammalian nontumorigenic epithelia cells of the small intestine and macrophages induced by individual strains of lactobacilli and bifidobacteria. Int Dairy J 19: 166-171
30. Roessler A, Friedrich U, Vogelsang H, Bauer A, Kaatz M, Hipler UC, Schmidt I, Jahreis G (2008) The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 38: 93-102
31. Roncaglia L, Amaretti A, Raimondi S, Leonardi A, Rossi M (2011) Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside. Appl Microbiol Biotechnol 92: 159-168
32. Rowland IR (2008) Prebiotics in human medicine. In: Versalovic J, Wilson M (eds) Therapeutic microbiology: probiotics and related strategies. American Society for Microbiology, Washington DC, pp 299-306
33. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E (2010) Safety assessment of probiotics for human use. Gut Microbes 1: 164-185
34. Santini C, Baffoni L, Gaggia F, Granata M, Gasbarri R, Di Gioia D (2010) Characterization of probiotic strains: an application as feed additives in poultry against Campylobacter jejuni. Int J Food Microbiol 141: S98-S108
35. SAS STAT (1988) User's guide. Release 6.03 edition. SAS Institute, Cary
36. Satokari RM, Vaughan EE, Akkermans ADL, Saarela M (2001) Bifidobacterial diversity in human feces detected by genusspecific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67: 504-513
37. Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D (2009) Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr 98: 1582-1588
38. Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D (2010) Lactobacillus reuteri DSM 17939 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126: 526-533
39. Savino F, Cordisco L, Tarasco V, Locatelli E, Di Gioia D, Oggero R (2011) Antagonistic effect of Lactobacillus strains against gasproducing coliforms isolated from colicky infants. BMC Microbiol 11: 157
40. Scardovi V, Casalicchio F, Vincenzi N (1979) Multiple electrophoretic forms of transaldolase and 6-phosphogluconic dehydrogenase and their relationships to the taxonomy and ecology of the bifidobacteria. Int J Syst Bacteriol 29: 312-327
41. Serikov I, Russel SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90: 859-904
42. Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL (2006) Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clin Exp Allergy 36: 1227-1235
43. Tremblay LN, Slutsky AS (2007) Ventilator- induced lung inujury: from the bench to the bedside. Intensive Care Med 32: 24-33
44. Van Hoek AH, Mayrhofer S, Domig K, Florez A, Ammor M, Mayo B, Aarts HM (2008) Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johsonii. Antimicrob Agents Chemother 52: 248-252
45. Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109: 678-684
46. Ventura M, Meylan V, Zink R (2003) Identification and tracing of Bifidobacterium species by use of enterobacterial repetitive intergenic consensus sequences. Appl EnvironMicrobiol 69: 4296-4301
47. Ventura M, Van Sinderen D, Fitzgerald GF, Zink R (2004) Insights into the taxonomy, genetics and physiology of bifidobacteria. Antonie Van Leeuwenhoek 86: 205-223
48. Ventura M, Turroni F, Ribbera A, Foroni E, Van Sideren D (2008) Bifidobacteria: the model human gut commensal. In: Versalovic J, Wilson M (eds) Therapeutic microbiology: probiotics and related strategies. American Society for Microbiology, Washington, DC, pp 35-50
49. Wada M, Nagata S, Saito M, Shimizu T, Yamashiro Y, Matsuki T (2010) Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18: 751-757
50. Wang C, Shoji H, Sato H, Nagata S, Ohtsuka Y, Shimizu T (2007) Effects of oral administration of Bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants. J Pediatr Gastroenterol Nutr 44: 252-257